MedAssets Company Profile (NASDAQ:MDAS)

About MedAssets

MedAssets logoMedAssets, Inc. (MedAssets) provides technology-enabled products and services to healthcare organizations, including hospitals, health systems, non-acute healthcare providers, payers, other service providers and product manufacturers. The Company operates its business through two business segments: Spend and Clinical Resource Management (SCM) and Revenue Cycle Management (RCM). The SCM segment delivers market insight, performance improvement advisory and cost management capabilities to healthcare providers. The RCM segment provides revenue cycle management solutions to healthcare providers, primarily hospitals and health systems. The Company's technology-enabled solutions are delivered through the Company-hosted software or software as a service (SaaS) or Web-based applications. Its Web-based applications employ cloud computing by using the Internet to deploy the Company's solutions across decentralized health care organizations, providing standardization and compliance.

Industry, Sector and Symbol:
  • Sector: Technology
  • Industry: Healthcare Information Services
  • Sub-Industry: Health Care Technology
  • Exchange: NASDAQ
  • Symbol: MDAS
  • CUSIP: 58404510
Key Metrics:
  • Previous Close: $0.00
  • 50 Day Moving Average: $30.97
  • 200 Day Moving Average: $25.46
  • 52-Week Range: $17.00 - $31.35
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 22.55
  • P/E Growth: 0.00
  • Market Cap: $N/A
Additional Links:
Companies Related to MedAssets:

Analyst Ratings

Consensus Ratings for MedAssets (NASDAQ:MDAS) (?)
Ratings Breakdown: 8 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $31.18 (0.56% downside)

Analysts' Ratings History for MedAssets (NASDAQ:MDAS)
DateFirmActionRatingPrice TargetDetails
1/27/2016William BlairReiterated RatingMarket PerformView Rating Details
1/25/2016Canaccord GenuityReiterated RatingHoldView Rating Details
11/20/2015Leerink SwannReiterated RatingHold$22.00 -> $31.35View Rating Details
11/17/2015JPMorgan Chase & Co.Initiated CoverageNeutral$19.00 -> $31.00View Rating Details
11/3/2015SunTrust Banks Inc.DowngradeBuy -> NeutralView Rating Details
11/3/2015Wells Fargo & Co.DowngradeOutperform -> Market PerformView Rating Details
11/3/2015Jefferies GroupDowngradeBuy -> Hold$25.00 -> $31.35View Rating Details
11/3/2015FBR & CoBoost Price TargetMarket Perform$20.00 -> $31.00View Rating Details
11/2/2015Piper Jaffray Cos.UpgradeUnderweight -> NeutralView Rating Details
10/21/2015Avondale PartnersInitiated CoverageOutperform$27.50View Rating Details
10/1/2015Deutsche Bank AGReiterated RatingHold$22.00 -> $23.00View Rating Details
10/1/2015Topeka Capital MarketsLower Price TargetHold$23.00 -> $22.00View Rating Details
8/3/2015Royal Bank Of CanadaBoost Price TargetSector Perform$18.00 -> $20.00View Rating Details
7/14/2015Evercore Partners Inc.Reiterated RatingBuy -> HoldView Rating Details
7/14/2015Evercore ISIDowngradeBuy -> Hold$24.00View Rating Details
6/18/2015StephensReiterated RatingMarket PerformView Rating Details
6/17/2015Oppenheimer Holdings Inc.Initiated CoverageMarket PerformView Rating Details
5/24/2015Citigroup Inc.Reiterated RatingHold$21.50View Rating Details
3/3/2015Bank of America Corp.DowngradeNeutral -> UnderperformView Rating Details
1/16/2015Robert W. BairdDowngradeOutperform -> Neutral$30.00 -> $20.00View Rating Details
11/17/2014Raymond James Financial Inc.DowngradeOutperform -> Market Perform$27.00View Rating Details
(Data available from 10/28/2014 forward)


Earnings History for MedAssets (NASDAQ:MDAS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2015Q315$0.28$0.32$187.34 million$117.20 millionViewN/AView Earnings Details
7/29/2015Q2$0.27$0.31$187.45 million$190.40 millionViewListenView Earnings Details
4/29/2015Q115$0.30$0.31$184.33 million$185.58 millionViewN/AView Earnings Details
2/17/2015Q414$0.39$0.39$195.00 million$198.20 millionViewN/AView Earnings Details
10/29/2014Q314$0.31$0.34$172.50 million$175.70 millionViewListenView Earnings Details
7/30/2014Q214$0.29$0.30$175.70 million$175.42 millionViewListenView Earnings Details
4/30/2014Q114$0.33$0.32$172.37 millionViewListenView Earnings Details
2/26/2014Q413$0.28$0.30$165.64 million$170.50 millionViewListenView Earnings Details
10/30/2013Q313$0.30$0.31$166.78 million$166.40 millionViewN/AView Earnings Details
7/31/2013Q2 2013$0.26$0.30$167.64 million$170.70 millionViewN/AView Earnings Details
5/1/2013Q1 2013$0.30$0.41$164.75 million$172.84 millionViewN/AView Earnings Details
2/20/2013Q4 2012$0.28$0.27$159.84 million$163.80 millionViewN/AView Earnings Details
10/30/2012$0.26$0.32ViewN/AView Earnings Details
8/1/2012$0.22$0.28ViewN/AView Earnings Details
5/2/2012$0.18$0.24ViewN/AView Earnings Details
2/23/2012$0.32$0.32ViewN/AView Earnings Details
11/3/2011$0.16$0.26ViewN/AView Earnings Details
8/1/2011$0.16$0.23ViewN/AView Earnings Details
5/5/2011$0.16$0.17ViewN/AView Earnings Details
2/24/2011$0.22$0.18ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for MedAssets (NASDAQ:MDAS)
Current Year EPS Consensus Estimate: $1.30 EPS
Next Year EPS Consensus Estimate: $1.39 EPS


Dividend History for MedAssets (NASDAQ:MDAS)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for MedAssets (NASDAQ:MDAS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/26/2015John A BardisDirectorSell2,000$19.73$39,460.00View SEC Filing  
2/24/2015John A BardisDirectorSell100,000$19.45$1,945,000.00View SEC Filing  
2/19/2015R Halsey WiseCEOBuy110,300$18.15$2,001,945.00View SEC Filing  
11/26/2014Keith L ThurgoodInsiderSell5,681$19.54$111,006.74View SEC Filing  
11/12/2014Harris Iv HymanDirectorSell3,334$20.50$68,347.00View SEC Filing  
11/11/2014John A BardisCEOSell100,000$20.02$2,002,000.00View SEC Filing  
11/7/2014John A BardisCEOSell191,833$20.74$3,978,616.42View SEC Filing  
11/4/2014John A BardisCEOSell208,167$21.48$4,471,427.16View SEC Filing  
10/28/2014Jonathan H GlennInsiderSell7,300$22.62$165,126.00View SEC Filing  
10/27/2014Jonathan H GlennInsiderSell500$22.50$11,250.00View SEC Filing  
8/13/2014Terrence J MulliganDirectorSell1,000$21.97$21,970.00View SEC Filing  
7/10/2014Terrence J MulliganDirectorSell1,000$21.97$21,970.00View SEC Filing  
7/1/2014Charles O GarnerCFOSell3,167$22.81$72,239.27View SEC Filing  
6/12/2014Terrence J MulliganDirectorSell1,000$23.30$23,300.00View SEC Filing  
5/14/2014Terrence MulliganDirectorSell1,000$22.93$22,930.00View SEC Filing  
5/2/2014R Halsey WiseDirectorBuy8,950$22.31$199,674.50View SEC Filing  
4/10/2014Terrence MulliganDirectorSell1,000$24.56$24,560.00View SEC Filing  
3/13/2014Terrence MulliganDirectorSell1,000$25.24$25,240.00View SEC Filing  
2/28/2014Charles GarnerCFOSell8,949$24.05$215,223.45View SEC Filing  
2/24/2014Terrence MulliganDirectorSell1,000$21.97$21,970.00View SEC Filing  
1/16/2014Charles GarnerCFOSell15,207$20.83$316,761.81View SEC Filing  
1/16/2014Terrence MulliganDirectorSell2,000$21.97$43,940.00View SEC Filing  
11/26/2013John RutherfordDirectorSell13,000$21.41$278,330.00View SEC Filing  
11/21/2013Bruce WessonDirectorSell60,263$20.54$1,237,802.02View SEC Filing  
11/15/2013Terrence MulliganDirectorSell1,000$21.97$21,970.00View SEC Filing  
11/8/2013John BardisCEOSell200,000$22.04$4,408,000.00View SEC Filing  
10/22/2013Lance M CulbrethCAOSell2,000$26.45$52,900.00View SEC Filing  
10/8/2013Terrence MulliganDirectorSell1,000$24.64$24,640.00View SEC Filing  
9/17/2013Terrence MulliganDirectorSell1,000$24.21$24,210.00View SEC Filing  
9/11/2013Lance M CulbrethCAOSell4,000$24.23$96,920.00View SEC Filing  
9/10/2013Jonathan H GlennInsiderSell12,268$24.00$294,432.00View SEC Filing  
8/29/2013Charles GarnerCFOSell2,017$23.02$46,431.34View SEC Filing  
8/29/2013Harris Iv HymanDirectorSell3,199$23.26$74,408.74View SEC Filing  
8/26/2013Harris Iv HymanDirectorSell5,985$23.50$140,647.50View SEC Filing  
8/23/2013C PiccoloDirectorSell17,487$22.94$401,151.78View SEC Filing  
8/23/2013John BardisCEOSell17,304$23.04$398,684.16View SEC Filing  
8/15/2013John BardisCEOSell10,000$22.87$228,700.00View SEC Filing  
8/14/2013Terrence MulliganDirectorSell5,000$23.50$117,500.00View SEC Filing  
8/9/2013John RutherfordDirectorSell50,000$23.62$1,181,000.00View SEC Filing  
8/5/2013Lance M CulbrethCAOSell22,866$23.34$533,692.44View SEC Filing  
8/2/2013Gregory StrobelInsiderSell4,025$22.78$91,689.50View SEC Filing  
8/2/2013Terrence MulliganDirectorSell29,446$23.39$688,741.94View SEC Filing  
7/23/2013Michael Patrick NolteCOOSell20,000$21.04$420,800.00View SEC Filing  
7/17/2013Lance M CulbrethCAOSell4,500$20.45$92,025.00View SEC Filing  
7/16/2013Michael Patrick NolteCOOSell19,222$19.63$377,327.86View SEC Filing  
7/16/2013Rand A BallardInsiderSell13,163$20.00$263,260.00View SEC Filing  
7/16/2013Terrence J MulliganDirectorSell55,000$20.00$1,100,000.00View SEC Filing  
5/10/2013Lance M CulbrethCAOSell16,000$18.54$296,640.00View SEC Filing  
3/25/2013Charles O GarnerCFOSell15,038$19.38$291,436.44View SEC Filing  
11/27/2012Gregory A StrobelInsiderSell10,000$16.24$162,400.00View SEC Filing  
11/27/2012John A BardisCEOSell107,550$16.51$1,775,650.50View SEC Filing  
11/14/2012John A BardisCEOSell71,340$16.34$1,165,695.60View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for MedAssets (NASDAQ:MDAS)
DateHeadline logoMedAssets Has Returned 43.2% Since SmarTrend Recommendation (MDAS) (NASDAQ:MDAS) - August 13 at 9:01 AM
News IconMedAssets, Inc. (NASDAQ:MDAS) Broker Price Targets For The Coming Week - Share Trading News (NASDAQ:MDAS) - May 9 at 9:04 AM
News IconAverage Analyst Rating for MedAssets, Inc. (NASDAQ:MDAS) - B.O.D.Y Confidential (NASDAQ:MDAS) - May 4 at 7:50 AM
News IconNext Weeks Broker Price Targets For MedAssets, Inc. (NASDAQ:MDAS) - Share Trading News (NASDAQ:MDAS) - April 24 at 9:15 AM
News IconNew Analyst Ratings On MedAssets, Inc. (NASDAQ:MDAS) - Risers & Fallers (NASDAQ:MDAS) - April 23 at 9:39 AM
News IconMedAssets, Inc. (NASDAQ:MDAS) Share Rating Recap - The Post (NASDAQ:MDAS) - April 22 at 10:20 AM logoMedAssets, Inc. (NASDAQ:MDAS) Analyst Recommendation Outlook - Clinton Financial (NASDAQ:MDAS) - April 15 at 1:20 PM
News IconMedAssets, Inc. (NASDAQ:MDAS) Latest Broker Coverage - Risers & Fallers (NASDAQ:MDAS) - April 14 at 2:40 PM
News IconCurrent Price Targets For MedAssets, Inc. (NASDAQ:MDAS) - Risers & Fallers (NASDAQ:MDAS) - April 12 at 1:16 PM
News IconEarnings Watch on MedAssets, Inc. (NASDAQ:MDAS) - (NASDAQ:MDAS) - April 12 at 1:15 PM
News IconRecently Changed Price Targets On MedAssets, Inc. (NASDAQ:MDAS) - Risers & Fallers (NASDAQ:MDAS) - April 9 at 12:42 PM logoIs MedAssets, Inc. (NASDAQ:MDAS) a Consensus Buy? - Clinton Financial (NASDAQ:MDAS) - April 8 at 1:26 PM
News IconAnalyst Ratings Check MedAssets, Inc. (NASDAQ:MDAS) - Business Standard Tribune (NASDAQ:MDAS) - April 7 at 1:46 PM
News IconBroker Roundup For MedAssets, Inc. (NASDAQ:MDAS) - Share Trading News (NASDAQ:MDAS) - April 7 at 1:46 PM
News IconMedAssets, Inc. (NASDAQ:MDAS) - Broker Update - Risers & Fallers (NASDAQ:MDAS) - April 5 at 2:49 PM
News IconLatest Analyst Ratings For MedAssets, Inc. (NASDAQ:MDAS) - Share Trading News (NASDAQ:MDAS) - April 5 at 2:49 PM
News IconEarnings View for MedAssets, Inc. (NASDAQ:MDAS) - (NASDAQ:MDAS) - April 5 at 2:49 PM
News IconBroker Outlook For The Week Ahead MedAssets, Inc. (NASDAQ:MDAS) - Share Trading News (NASDAQ:MDAS) - April 3 at 2:33 PM logoFreshford Capital Management Llc Increased Medassets Inc (NASDAQ:MDAS) by $40.95 Million as Shares Rose - Clinton Financial (NASDAQ:MDAS) - April 2 at 1:28 PM logoShould Investors Buy MedAssets, Inc. (NASDAQ:MDAS)? - Clinton Financial (NASDAQ:MDAS) - April 2 at 1:28 PM
News IconEarnings Outlook on MedAssets, Inc. (NASDAQ:MDAS) - (NASDAQ:MDAS) - March 30 at 2:37 PM
News IconAverage Rating Watch MedAssets, Inc. (NASDAQ:MDAS) - Business Standard Tribune (NASDAQ:MDAS) - March 30 at 2:37 PM
News IconAverage Analyst Rating Update on MedAssets, Inc. (NASDAQ:MDAS) - Business Standard Tribune (NASDAQ:MDAS) - March 17 at 2:14 PM logoWhat Is The ABR Of MedAssets, Inc. (NASDAQ:MDAS)? - Investor Newswire (NASDAQ:MDAS) - March 17 at 2:14 PM logoCan MedAssets, Inc. (NASDAQ:MDAS) Top Street's Expectations? - Stocks Daily (NASDAQ:MDAS) - March 17 at 2:14 PM logoSmall-Caps: Hedge Fund Favorites (NASDAQ:MDAS) - March 11 at 4:30 PM
News IconEarnings Glance MedAssets, Inc. (NASDAQ:MDAS) - Business Standard Tribune (NASDAQ:MDAS) - March 10 at 1:54 PM logoStock Rating & Analysis on MedAssets, Inc. (NASDAQ:MDAS) - (NASDAQ:MDAS) - March 3 at 2:58 PM logoFreshford Capital Management Llc Increased Medassets Inc (NASDAQ:MDAS) by $40.95 Million as Shares Rose (NASDAQ:MDAS) - February 17 at 12:52 PM
News IconUpdated Price Targets On MedAssets, Inc. (NASDAQ:MDAS) - Risers & Fallers (NASDAQ:MDAS) - February 16 at 12:47 PM logoJunk Bond Issuance Gained Traction: 5 Key Deals (NASDAQ:MDAS) - February 10 at 12:26 PM logoLeveraged Loan Funds Continued to Witness Outflows Last Week (NASDAQ:MDAS) - February 4 at 12:07 AM logoMedAssets, Inc. (NASDAQ:MDAS): Quarterly Earnings Update - Investor Newswire (NASDAQ:MDAS) - February 3 at 11:32 AM logoLeveraged Loans Issuance Fell Last Week (NASDAQ:MDAS) - January 30 at 9:07 PM
News IconMedAssets, Inc. (NASDAQ:MDAS) Short Interest Update - Market Briefing (NASDAQ:MDAS) - January 29 at 11:24 AM logoMedAssets Named Category Leader in “2015/2016 Best in KLAS” Report (NASDAQ:MDAS) - January 29 at 8:30 AM logoVizient, Inc. -- Moody's assigns B2 CFR to Vizient, Inc.; stable outlook (NASDAQ:MDAS) - January 28 at 1:34 PM logoNew Lifetime High Reached By MedAssets (MDAS) (NASDAQ:MDAS) - January 27 at 6:12 PM logoMEDASSETS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive Ag (NASDAQ:MDAS) - January 27 at 3:22 PM logoPamplona Capital Management Completes Acquisition of MedAssets for $2.75 Billion - GlobeNewswire (press release) (NASDAQ:MDAS) - January 27 at 10:55 AM
News IconAnalyst Coverage Updates - MedAssets, Inc. (NASDAQ:MDAS) - Risers & Fallers (NASDAQ:MDAS) - January 27 at 10:55 AM logoPamplona Capital Management Completes Acquisition of MedAssets for $2.75 Billion (NASDAQ:MDAS) - January 27 at 10:30 AM logoPamplona Capital Management Completes Acquisition of MedAssets (NASDAQ:MDAS) - January 27 at 10:30 AM logoMedAssets Inc. (MDAS) is Trading Higher on Unusual Volume for January 22 - (NASDAQ:MDAS) - January 22 at 5:56 PM logoMedAssets, Inc. (NASDAQ:MDAS) - Stock Sentiment And ABR Update - Investor Newswire (NASDAQ:MDAS) - January 21 at 5:57 PM logoPamplona Capital Management Names CEO, Executive Leadership Team for Combined MedAssets-Precyse Enterprise (NASDAQ:MDAS) - January 20 at 9:45 AM logoMedAssets' Shareholders Approve Takeover by Pamplona (NASDAQ:MDAS) - January 15 at 2:50 PM logoMEDASSETS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statem (NASDAQ:MDAS) - January 14 at 4:13 PM logoMedAssets' Stockholders Approve Merger With Pamplona Capital Management (NASDAQ:MDAS) - January 14 at 2:26 PM logoMedAssets, Inc. (New). -- Moody's assigns B3 CFR to MedAssets, Inc. (New); rates LBO financing (NASDAQ:MDAS) - January 6 at 3:30 PM


MedAssets (NASDAQ:MDAS) Chart for Friday, October, 28, 2016

Last Updated on 10/28/2016 by Staff